Lab School Day Study for CONCERTA of Older Children With ADHD
Phase 4
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: Placebo/ CONCERTA (methylphenidate HCl)
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 78
- Registration Number
- NCT00799409
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
- First Posted Date
- 2008-10-13
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 108
- Registration Number
- NCT00771758
Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
Phase 4
Completed
- Conditions
- Contraception
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 355
- Registration Number
- NCT00745901
A Complicated Skin and Soft-tissue Infection Patient Registry
Completed
- Conditions
- Staphylococcal Skin InfectionsDiabetic Foot InfectionsSurgical Wound InfectionAbscessCellulitis
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 1081
- Registration Number
- NCT00737269
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
Phase 4
Completed
- Conditions
- Psychotic DisordersSchizophreniaSchizoaffective Disorder
- Interventions
- Drug: Treatment as usual (TAU), Paliperidone ER
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2014-07-25
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 121
- Registration Number
- NCT00535145
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Terminated
- Conditions
- Schizophrenia
- Interventions
- Drug: Atypical antipsychotics (AAP)
- First Posted Date
- 2007-06-20
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Target Recruit Count
- 43
- Registration Number
- NCT00488891
© Copyright 2025. All Rights Reserved by MedPath